This decree sets out the contractual framework between the managing body and the "Organismes Gestionnaires Délégués" (Delegated Management Organizations) of the universal health insurance scheme.
The decree defines the values and nomenclatures for pharmaceutical acts and products covered by the universal health insurance scheme.
The objective of this decree is to define the modalities and procedures for concluding, suspending and terminating agreements governing relations between the Health Insurance Fund (IPS-CNAM) and healthcare providers.